Protein family
The protein has not catalytic activity
Protein sequence
Protein function
Catalytic activity
PDB | Resolution (Å) | PDB name |
---|---|---|
1LJ2 | 2.38 | Recognition of eIF4G by Rotavirus NSP3 reveals a basis for mRNA circularization |
1UG3 | 2.24 | C-terminal portion of human eIF4GI |
2W97 | 2.29 | Crystal Structure of eIF4E Bound to Glycerol and eIF4G1 peptide |
4AZA | 2.16 | Improved eIF4E binding peptides by phage display guided design. |
4F02 | 2.0 | Crystal structure of the PABP-binding site of eIF4G in complex with RRM1-2 of PABP and poly(A) |
5EHC | 2.4 | Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
5EI3 | 1.71 | Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
5EIR | 2.69 | Co-crystal structure of eIF4E with nucleotide mimetic inhibitor. |
5T46 | 1.53 | Crystal structure of the human eIF4E-eIF4G complex |
5ZK5 | 2.25 | Stapled-peptides tailored against initiation of translation |
6ZMW | 3.7 | Structure of a human 48S translational initiation complex |
GO ontology
|
GO term | GO description |
---|---|---|
Biological Process | GO:0001662 | behavioral fear response |
Biological Process | GO:0002191 | cap-dependent translational initiation |
Biological Process | GO:0031669 | cellular response to nutrient levels |
Biological Process | GO:0097009 | energy homeostasis |
Biological Process | GO:0030324 | lung development |
Biological Process | GO:0009059 | macromolecule biosynthetic process |
Biological Process | GO:0035278 | miRNA-mediated gene silencing by inhibition of translation |
Biological Process | GO:0010507 | negative regulation of autophagy |
Biological Process | GO:1901215 | negative regulation of neuron death |
Biological Process | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation |
Biological Process | GO:0030182 | neuron differentiation |
Biological Process | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle |
Biological Process | GO:0010942 | positive regulation of cell death |
Biological Process | GO:0030307 | positive regulation of cell growth |
Biological Process | GO:1905537 | positive regulation of eukaryotic translation initiation factor 4F complex assembly |
Biological Process | GO:1905612 | positive regulation of mRNA cap binding |
Biological Process | GO:0045666 | positive regulation of neuron differentiation |
Biological Process | GO:0033138 | positive regulation of peptidyl-serine phosphorylation |
Biological Process | GO:0051247 | positive regulation of protein metabolic process |
Biological Process | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress |
Biological Process | GO:0080135 | regulation of cellular response to stress |
Biological Process | GO:0060964 | regulation of miRNA-mediated gene silencing |
Biological Process | GO:1905696 | regulation of polysome binding |
Biological Process | GO:1905606 | regulation of presynapse assembly |
Biological Process | GO:0006446 | regulation of translational initiation |
Biological Process | GO:0045471 | response to ethanol |
Biological Process | GO:0006412 | translation |
Biological Process | GO:0006413 | translational initiation |
Molecular Function | GO:0005524 | ATP binding |
Molecular Function | GO:0003723 | RNA binding |
Molecular Function | GO:0008190 | eukaryotic initiation factor 4E binding |
Molecular Function | GO:0042802 | identical protein binding |
Molecular Function | GO:0003729 | mRNA binding |
Molecular Function | GO:0060090 | molecular adaptor activity |
Molecular Function | GO:0008135 | translation factor activity, RNA binding |
Molecular Function | GO:0003743 | translation initiation factor activity |
Molecular Function | GO:0031369 | translation initiation factor binding |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0010494 | cytoplasmic stress granule |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0016281 | eukaryotic translation initiation factor 4F complex |
Cellular Component | GO:0016020 | membrane |
Cellular Component | GO:0005634 | nucleus |
Cellular Component | GO:0005844 | polysome |
Cellular Component | GO:0098794 | postsynapse |
Reactome
|
Reactome Name | Node type
|
Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-1169408 | ISG15 antiviral mechanism | Leaf | R-HSA-168256 | Immune System |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-166208 | mTORC1-mediated signalling | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-429947 | Deadenylation of mRNA | Leaf | R-HSA-8953854 | Metabolism of RNA |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | Leaf | R-HSA-8953854 | Metabolism of RNA |
R-HSA-72649 | Translation initiation complex formation | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | Internal node | R-HSA-392499 | Metabolism of proteins |
R-HSA-72702 | Ribosomal scanning and start codon recognition | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | Leaf | R-HSA-392499 | Metabolism of proteins |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | Leaf | R-HSA-8953854 | Metabolism of RNA |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | Leaf | R-HSA-8953854 | Metabolism of RNA |
Location
|
ECO term
|
Pubmed |
---|---|---|
Cytoplasm | ECO:0000269 | PubMed:17984221 |
Cytoplasm, Stress granule | ECO:0000269 | PubMed:22872150 |
Nucleus | ECO:0000269 | PubMed:17984221 |
HPO ID
|
HPO name |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0000338 | Hypomimic face |
HP:0000651 | Diplopia |
HP:0000713 | Agitation |
HP:0000716 | Depression |
HP:0000726 | Dementia |
HP:0000741 | Apathy |
HP:0000744 | Low frustration tolerance |
HP:0001268 | Mental deterioration |
HP:0001300 | Parkinsonism |
HP:0001332 | Dystonia |
HP:0001824 | Weight loss |
HP:0002015 | Dysphagia |
HP:0002063 | Rigidity |
HP:0002067 | Bradykinesia |
HP:0002120 | Cerebral cortical atrophy |
HP:0002171 | Gliosis |
HP:0002172 | Postural instability |
HP:0002304 | Akinesia |
HP:0002322 | Resting tremor |
HP:0002359 | Frequent falls |
HP:0002360 | Sleep disturbance |
HP:0002362 | Shuffling gait |
HP:0002367 | Visual hallucinations |
HP:0002548 | Parkinsonism with favorable response to dopaminergic medication |
HP:0003394 | Muscle spasm |
HP:0003584 | Late onset |
HP:0003587 | Insidious onset |
HP:0003596 | Middle age onset |
HP:0004409 | Hyposmia |
HP:0004926 | Orthostatic hypotension due to autonomic dysfunction |
HP:0005340 | Spastic/hyperactive bladder |
HP:0012450 | Chronic constipation |
HP:0031435 | Monotonic speech |
HP:0100315 | Lewy bodies |
HP:0100660 | Dyskinesia |
HP:0100710 | Impulsivity |
HP:0100753 | Schizophrenia |
Disease name | MONDO ID
|
ICD10
|
ICD10 chapter
|
OMIM
|
Orphanet
|
---|---|---|---|---|---|
parkinson disease 18- autosomal dominant- susceptibility to | MONDO:0013653 | G20 | chapter6, Diseases of the nervous system | OMIM:614251 |